» Articles » PMID: 32616004

Prevalence, Awareness, Treatment, and Control of Hypertension in Older People: Results from the Population-based KORA-age 1 Study

Overview
Publisher Biomed Central
Specialty Public Health
Date 2020 Jul 4
PMID 32616004
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypertension remains a significant modifiable risk factor for cardiovascular diseases and a major determinant of morbidity and mortality. We aimed to describe sex-stratified age-standardized estimates of prevalence, awareness, treatment and control of hypertension, and their associated factors in older adults.

Methods: The KORA-Age1 is a population-based cross-sectional survey carried out in 2008/2009 on individuals aged 65-94 years in Augsburg region, Germany. Blood pressure measurements were available for 1052 out of 1079 persons who participated in the physical examination. Factors associated with prevalence, awareness and control of hypertension were investigated by multivariable logistic regression.

Results: The overall prevalence of hypertension (≥140/90 mmHg) was 73.8% [95% confidence interval (CI), 69.3-77.9], representing 74.8% (95% CI, 68.4-80.2) in men and 73.5% (95% CI, 66.8-79.3) in women. Among those with hypertension, 80.2% (95% CI, 75.3-84.4) were aware of their hypertensive condition and 74.4% (95% CI, 69.2-79.1) were on treatment for hypertension. Among those aware of their hypertension status, 92.8% (95% CI, 88.8-95.6) were on treatment and 53.7% (95% CI, 47.0-60.1) had their blood pressure controlled. Hypertension was more frequent in individuals who were older, obese, or had diabetes. Higher education attainment or presence of comorbidities was associated with higher level of hypertension awareness. Individuals taking three antihypertensive drug classes were more likely to have controlled hypertension compared with those taking one antihypertensive drug class, odds ratio (OR), 1.85 (95% CI, 1.14-2.99).

Conclusion: Our findings identified high prevalence of hypertension and relevant health gaps on awareness, treatment and suboptimal control of hypertension in older adults in Germany. Screening for hypertension should especially target older adults with low educational attainment and 'healthy' elderly with less contact to physicians.

Citing Articles

Prevalence, awareness, treatment and control of hypertension in the Brazilian population and sociodemographic associated factors: data from National Health Survey.

Vieira M, Tonaco L, Souza M, Andrade F, Malta D, Felisbino-Mendes M BMC Public Health. 2025; 25(1):781.

PMID: 40001079 PMC: 11863439. DOI: 10.1186/s12889-025-22008-8.


Prevalence of Metabolic Syndrome and Specific Cardiovascular Risk Factors among Older Persons in the Philippines: Results from the 8th Philippine National Nutrition Survey.

Lusica P, Jimeno C Acta Med Philipp. 2024; 57(12):5-11.

PMID: 39429764 PMC: 11484595. DOI: 10.47895/amp.vi0.5719.


A Retrospective Analysis of the Underlying Health Status of Patients Treated for Stroke in the Emergency Department of a Community Hospital Situated in a Health Professional Shortage Area.

Voura E, Jorgensen T, Stulb J, Mulligan M, Padalino D Cureus. 2024; 16(8):e68150.

PMID: 39347207 PMC: 11438578. DOI: 10.7759/cureus.68150.


The impact of population ageing on the burden of chronic kidney disease.

Chesnaye N, Ortiz A, Zoccali C, Stel V, Jager K Nat Rev Nephrol. 2024; 20(9):569-585.

PMID: 39025992 DOI: 10.1038/s41581-024-00863-9.


Coronary risk factor profiles according to different age categories in premature coronary artery disease patients who have undergone percutaneous coronary intervention.

Nazli S, Rosman A, Mohd Kasim N, Al-Khateeb A, Ul-Saufie A, Md Radzi A Sci Rep. 2024; 14(1):15326.

PMID: 38961082 PMC: 11222582. DOI: 10.1038/s41598-024-53539-6.


References
1.
White W . Cardiovascular risk, hypertension, and NSAIDs. Curr Rheumatol Rep. 2007; 9(1):36-43. DOI: 10.1007/s11926-007-0020-3. View

2.
Goeres L, Williams C, Eckstrom E, Lee D . Pharmacotherapy for hypertension in older adults: a systematic review. Drugs Aging. 2014; 31(12):897-910. DOI: 10.1007/s40266-014-0219-8. View

3.
Peters A, Doring A, Ladwig K, Meisinger C, Linkohr B, Autenrieth C . [Multimorbidity and successful aging: the population-based KORA-Age study]. Z Gerontol Geriatr. 2012; 44 Suppl 2:41-54. DOI: 10.1007/s00391-011-0245-7. View

4.
Malhotra R, Chan A, Malhotra C, Ostbye T . Prevalence, awareness, treatment and control of hypertension in the elderly population of Singapore. Hypertens Res. 2010; 33(12):1223-31. DOI: 10.1038/hr.2010.177. View

5.
Neuhauser H, Diederichs C, Boeing H, Felix S, Junger C, Lorbeer R . Hypertension in Germany. Dtsch Arztebl Int. 2017; 113(48):809-815. PMC: 5241792. DOI: 10.3238/arztebl.2016.0809. View